
Warburg Pincus Nears $7 Billion Deal for Specialty Pharmacy PANTHERx, WSJ Reports
Private equity firm Warburg Pincus is reportedly in advanced talks to acquire PANTHERx Rare for over $7 billion, including debt. The deal, in partnership with Abu Dhabi Investment Authority, highlights growing private equity interest in specialized healthcare assets.







